Guru Ownership Trend
Guru Analysis for Vertex Pharmaceuticals Incorporated (VRTX)
Vertex Pharmaceuticals Incorporated (VRTX), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 10 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $560.25 M.
Top institutional holders include Cliff Asness and Renaissance Technologies (RenTech).
Institutional sentiment is currently Strongly Bullish. This is evidenced by a $70.99 M net inflow during the quarter.
Recent activity highlights Cliff Asness who increased their stake by 260.3%. Conversely, Manning & Napier Group reduced exposure by 99.1%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for Vertex Pharmaceuticals Incorporated (VRTX)
Major holders include Cliff Asness ($305 M), Renaissance Technologies (RenTech) ($158.96 M), Tweedy Browne ($19.93 M). According to the latest reported data, 10 tracked investment managers collectively hold approximately 1.09 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $70.99 M, with 3 managers increasing positions and 7 managers reducing holdings.
During the most recent reporting period, 7 managers trimmed their positions, while 0 fully exited VRTX. The total reported sell value was $165.65 M.
Yes, 2 managers opened new positions in VRTX, and 1 increased their existing holdings. The total reported buy value was $236.64 M.
